Shenzhen - Delayed Quote • CNY
Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ)
At close: 3:04 PM GMT+8
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Cash Flows from Used in Operating Activities Direct
-141,322.72
-120,850.69
72,321.56
382,350.65
Operating Cash Flow
--
-120,850.69
72,321.56
382,350.65
Investing Cash Flow
-414,867.80
-508,335.04
-735,484.30
-548,501.16
Financing Cash Flow
125,168.18
282,986.73
349,610.89
912,690.94
End Cash Position
638,388.48
847,252.59
1,183,941.79
1,496,756.33
Capital Expenditure
-292,974.83
-459,410.87
-679,597.19
-449,237.09
Issuance of Debt
955,900.00
1,241,000.00
1,047,610.00
597,000.00
Repayment of Debt
-771,915.00
-830,488.00
-488,500.00
-596,500.00
Free Cash Flow
-434,297.55
-580,261.56
-607,275.63
-66,886.44
12/31/2020 - 12/22/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TBPH Theravance Biopharma, Inc.
9.14
-0.33%
MDXG MiMedx Group, Inc.
6.25
-2.88%
MIRM Mirum Pharmaceuticals, Inc.
24.49
+1.96%
CERO CERo Therapeutics Holdings, Inc.
1.4100
-1.40%
CLRB Cellectar Biosciences, Inc.
3.0200
-1.31%
OMER Omeros Corporation
3.0600
+0.66%
SGMT Sagimet Biosciences Inc.
3.9200
-6.00%
ASLN ASLAN Pharmaceuticals Limited
0.4480
-4.68%
XRTX XORTX Therapeutics Inc.
2.5900
-13.09%
NWBO Northwest Biotherapeutics, Inc.
0.4770
+3.67%